オプションチェーンは、Chanson Internationalの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Chanson Internationalの市場センチメントを評価します。.

Chanson International (NASDAQ:CHSN) 株価情報, オプションチェーン

Chanson International

Chanson International Holding manufactures and sells a wide selection of bakery products, seasonal products, and beverage products; some of these stores also offer eat-in services. It focuses to make healthy, nutritious, and ready-to-eat food through advanced facilities and industry research and to create a comfortable, yet distinguishable store environment in which customers can enjoy their products.

Chanson International Holding - Class A Ordinary Shares

Chanson International Holding

In addition, Janux expects to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of shares of its common stock at the public offering price, less the underwriting discounts and commissions.
The Company intends to use the net proceeds from the offering to advance clinical development of its internal product pipeline and for general corporate purposes.

News

Offerings

JANX

Janux Therapeutics Commences Underwritten Public Offering Of $300M Of Shares Of Its Common Stock

Poland&#8217;s GDP <a href="https://open.substack.com/pub/europeancapitalinsights/p/polands-gdp-set-for-continued-growth?r=3nmatg&amp;utm_campaign=post&amp;utm_medium=web" rel="nofollow">is set to expand further in 2025</a>, cementing its position as the European Union&#8217;s (EU) fastest-growing economy.
Polish economic growth is projected at 3.7% next year, supported by private consumption and investments, European Commission (EC) <a target="_blank" rel="noreferrer noopener" href="https://economy-finance.ec.europa.eu/economic-surveillance-eu-economies/poland/economic-forecast-poland_en#:~:text=The%20Polish%20economy%20rebounded%20sharply,projected%20in%20the%20Spring%20Forecast">data</a> showed. This expectation expands a strong rebound from 0.2% in 2023 to just over 3% in 2024, according to the forecast on November 15.
A strong financial sector, paired with tight labor markets, has also resulted in significant wage growth, driving increased consumer spending.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fec6b7cfb-0325-4922-9555-47fd1e56f456_1473x371.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fec6b7cfb-0325-4922-9555-47fd1e56f456_1473x371.png" alt="" /></a><figcaption class="wp-element-caption">Real GDP growth, 2021-2026, Source: <a target="_blank" rel="noreferrer noopener" href="https://thedocs.worldbank.org/en/doc/d5f32ef28464d01f195827b7e020a3e8-0500022021/related/mpo-pol.pdf">World Bank</a></figcaption></figure>
&#8220;Poland is one of the great economic growth success stories in the world over the last 30 years,&#8221; Geoff Gottlieb, IMF senior regional representative for Central, Eastern and South-Eastern Europe, <a target="_blank" rel="noreferrer noopener" href="https://x.com/mmpiatkowski/status/1849730926126723474">said</a>.
Poland's GDP outperforms the EU and Germany, Europe's largest economy. The <a href="https://europeancapitalinsights.substack.com/p/european-commission-downgrades-eu" target="_blank" rel="noreferrer noopener nofollow">EC expects the EU GDP to grow</a> by a mere 0.8% this year and 1.5% in 2025. German GDP will contract by 0.1% in 2024 from a 0.1% expansion previously, the second consecutive year of negative growth, the EC said.
<h2 class="wp-block-heading">Consumption-Led Recovery is Driving Poland's GDP</h2>
The IMF staff wrote in a <a target="_blank" rel="noreferrer noopener" href="https://www.imf.org/en/News/Articles/2024/10/17/CS-poland-2024">report</a> published on October 17 that "a consumption-led recovery is underway" in Poland. It added that the "outlook is further supported by recently unlocked NextGen EU Funds (NGEU)."
NextGen EU is a financial package allocated to Poland from the EU&#8217;s &#8220;NextGenerationEU&#8221; recovery plan to help member states recover economically from the COVID-19 pandemic. The package funds investments in green energy, digitalization, and social cohesion.
In the second quarter of 2024, Poland recorded the EU's largest GDP growth at +1.5%.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F04d4e8d4-2aba-4909-8f1e-9c915c29a956_1000x608.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F04d4e8d4-2aba-4909-8f1e-9c915c29a956_1000x608.png" alt="" /></a><figcaption class="wp-element-caption">Quarterly GDP growth by EU country, Q2 2024, Source: <a target="_blank" rel="noreferrer noopener" href="https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Quarterly_national_accounts_-_GDP_and_employment#GDP_growth_by_EU_country">Eurostat</a></figcaption></figure>
<h2 class="wp-block-heading">Investment Key Driver of Poland's GDP Growth</h2>
Poland's corporate sector wages increased by 10.2% year-on-year (YoY) to $2,042 (PLN 8,316.57) in October 2024, following a 10.3% growth in the previous month and beating market expectations of a 10.1% increase.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd0962611-8b4f-487e-865d-dfa4cb85f2ec_1405x968.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd0962611-8b4f-487e-865d-dfa4cb85f2ec_1405x968.png" alt="" /></a><figcaption class="wp-element-caption">Real Wage and Salary Enterprises, %YoY, Source: <a target="_blank" rel="noreferrer noopener" href="https://think.ing.com/snaps/wages-growth-labour-market-poland/">ING</a></figcaption></figure>
The average business employment decreased by 0.5% YoY in October, the same as in September. Despite this setback, Poland&#8217;s labor market remains solid, with unemployment remaining near record lows.
In 2025, EU-funded public investment is also forecasted to be a key driver of Poland's GDP growth. In February, the EU <a target="_blank" rel="noreferrer noopener" href="https://www.gov.pl/web/funds-regional-policy/european-funds-for-poland-unblocked">unblocked</a> around $147 billion (PLN 600 billion) for Poland from the Cohesion Policy and the National Recovery Plan. This is set to stimulate the Polish economy and boost investments.
The funds will help accelerate the green and digital transformation in the economy, increasing energy security and the use of modern technologies.
<h2 class="wp-block-heading">Poland GDP Growth Attracts Foreign Investments</h2>
Poland's strong economic performance has attracted international investments. Microsoft Corp. <a target="_blank" rel="noreferrer noopener" href="https://news.microsoft.com/europe/2023/04/26/microsoft-launches-its-first-datacenter-region-in-poland-bringing-new-opportunities-to-develop-the-digital-economy/">opened in 2023</a> a <a target="_blank" rel="noreferrer noopener" href="https://www.polskieradio.pl/395/7786/Artykul/3157569,US-giant-Microsoft-opens-USD-1-bn-cloud-centre-in-Poland">$1 billion </a>cloud region around Warsaw. It consists of three physical locations with one or more data centers.
"Microsoft's investment in Poland will accelerate our country's transformation into a technology hub for the Central and Eastern European region," Prime Minister Mateusz Morawiecki said at the time.
Microsoft <a target="_blank" rel="noreferrer noopener" href="https://windowsforum.com/threads/microsoft-launches-ai-training-program-in-poland-to-upskill-one-million-individuals.346814/">has also launched</a> an extensive AI training program in Poland, which aims to equip one million individuals with essential AI competencies by the end of 2025.
"Poland found the perfect blend of East and West," Ole Lehmann, the founder of The AI Solopreneur, wrote on <a target="_blank" rel="noreferrer noopener" href="https://x.com/itsolelehmann">X</a>. "They combined: Western innovation without the bureaucracy" and "Eastern work ethic &amp; traditional values without authoritarianism."
<h2 class="wp-block-heading">Challenges to Poland's GDP Growth</h2>
Polish industrial production remained close to stagnant in Q3 (0.6%YoY growth after +0.8%YoY in 2Q24) while construction remained in a recession. A decline in domestic retail trade added further pressure on the economy.
Poland, though, has little room for significant interest rate cuts next year, with wages and consumer prices buoying inflation and economic growth accelerating, the country's deputy central bank chief, Marta Kightley, <a target="_blank" rel="noreferrer noopener" href="https://www.msn.com/en-us/money/markets/poland-has-little-room-for-big-cuts-in-2025-central-banker-says/ar-AA1uRrks?ocid=BingNewsSerp">said</a>. Polish inflation eased in November to 4.6% YoY from 5% YoY in October.
"The decline in inflation in November is a temporary phenomenon," ING <a target="_blank" rel="noreferrer noopener" href="https://think.ing.com/snaps/temporary-decline-in-polands-inflation-in-november/">wrote</a> on November 29. "We project that it will rise in the first quarter of 2025, which will prevent the Monetary Policy Council from beginning its monetary easing cycle until then."
This has significantly slowed real wage growth, which dropped from 8.5% YoY to 6.0%. Higher electricity and gas bills may limit resources available for other household expenditures.
<h2 class="wp-block-heading">What Future Holds for Poland's GDP</h2>
Despite recording the fastest GDP growth in the EU and a record-low unemployment rate, labor shortages paired with low fertility rates and an aging population could pose a future threat to the Polish economy. In the past 30 years, Poland's birth rate decreased by 40%, standing at 1.33 in 2024.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fca5712c9-5ecc-4a94-91d0-33f88f488485_1018x1042.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fca5712c9-5ecc-4a94-91d0-33f88f488485_1018x1042.png" alt="" /></a><figcaption class="wp-element-caption">Crude rates of population change, 2021-2023, Source: <a target="_blank" rel="noreferrer noopener" href="https://ec.europa.eu/eurostat/databrowser/view/demo_gind/default/table?lang=en">Eurostat</a></figcaption></figure>
While the total EU population increased in 2023, the population fell in 7 countries, Latvia (-5.9) and Poland (-3.6), recording some of the highest decreases.
In response to labor market gaps and the need to attract foreign workers, Poland&#8217;s government announced its first comprehensive <a target="_blank" rel="noreferrer noopener" href="https://www.gov.pl/web/premier/uchwala-w-sprawie-przyjecia-dokumentu-odzyskac-kontrole-zapewnic-bezpieczenstwo-kompleksowa-i-odpowiedzialna-strategia-migracyjna-polski-na-lata-2025-2030">migration strategy</a> in October, a step toward addressing demographic challenges.
Many entrepreneurs are concerned that stricter immigration policies will make it harder to hire workers.
Disclaimer:
Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. European Capital Insights is not responsible for any financial decisions made based on the contents of this article. Readers may use this article for information and educational purposes only.
This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content&nbsp;or&nbsp;accuracy.

Emerging Markets

Economics

Poland's GDP Set for Growth in 2025 as EU's Fastest Economy

Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.58 by 15.52 percent. The company reported quarterly sales of $665.000 million which beat the analyst consensus estimate of $649.702 million by 2.35 percent. This is a 13.87 percent increase over sales of $584.000 million the same period last year.

Earnings

Earnings Beats

OKTA

Okta Q3 2025 Adj. EPS $0.67 Beats $0.58 Estimate, Sales $665.000M Beat $649.702M Estimate

Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) reported quarterly earnings of $2.41 per share which missed the analyst consensus estimate of $2.44 by 1.23 percent. The company reported quarterly sales of $9.440 billion which beat the analyst consensus estimate of $9.345 billion by 1.02 percent. This is a 8.26 percent increase over sales of $8.720 billion the same period last year.

Earnings Misses

Salesforce Q3 2025 Adj. EPS $2.41 Misses $2.44 Estimate, Sales $9.440B Beat $9.345B Estimate

Clouse Announces Plans to Retire to Join the NFL's Washington Commanders as President
The Campbell's Company (NASDAQ:<a href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) (Campbell's) announced today that its Board of Directors has elected Mick Beekhuizen to succeed Mark Clouse as President and CEO. Beekhuizen has also been elected a Director of the company, both effective Feb. 1, 2025. Until then, Beekhuizen will continue in his role as President, Meals &amp; Beverages.

Management

The Campbell's Company Elects Mick Beekhuizen Chief Executive Officer To Succeed Mark Clouse, Both Effective Feb. 1, 2025

8 analysts have shared their evaluations of Compass (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COMP#NYSE">COMP</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Compass, revealing an average target of $7.81, a high estimate of $9.50, and a low estimate of $6.00. Observing a 18.15% increase, the current average has risen from the previous average price target of $6.61. 
<img src="https://www.benzinga.com/files/images/story/2024/1733259694_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of Compass by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Ng</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$8.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Jason Helfstein</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$9.50</td>
<td>$8.50</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Jason Helfstein</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$8.50</td>
<td>$8.00</td>
</tr>
<tr>
<td>Matthew Bouley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$6.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$8.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Lloyd Walmsley</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$6.50</td>
<td>$4.40</td>
</tr>
<tr>
<td>Jason Helfstein</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$8.00</td>
<td>$6.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Compass. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Compass compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Compass's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Compass's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/COMP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Compass analyst ratings.</a>
<h2>Get to Know Compass Better</h2>
Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.
<h3>Unraveling the Financial Story of Compass</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Compass showcased positive performance, achieving a revenue growth rate of 11.71% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.
Net Margin: Compass's net margin excels beyond industry benchmarks, reaching -0.11%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Compass's ROE excels beyond industry benchmarks, reaching -0.41%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Compass's ROA stands out, surpassing industry averages. With an impressive ROA of -0.14%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Compass's debt-to-equity ratio is below the industry average at 1.19, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

COMP

What Analysts Are Saying About Compass Stock

Throughout the last three months, 10 analysts have evaluated ONEOK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated ONEOK and provided 12-month price targets. The average target is $105.5, accompanied by a high estimate of $132.00 and a low estimate of $94.00. Surpassing the previous average price target of $94.78, the current average has increased by 11.31%.
<img src="https://www.benzinga.com/files/images/story/2024/1733259682_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive ONEOK is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$107.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Brian Reynolds</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$132.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$99.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Michael Blum</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$107.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$99.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Sunil Sibal</td>
<td>Seaport Global</td>
<td>Raises</td>
<td>Buy</td>
<td>$103.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Jean Ann Salisbury</td>
<td>B of A Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$105.00</td>
<td>-</td>
</tr>
<tr>
<td>Elvira Scotto</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$98.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$94.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Robert Kad</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$111.00</td>
<td>$103.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ONEOK. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ONEOK compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of ONEOK's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of ONEOK's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/OKE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on ONEOK analyst ratings.</a>
<h2>Discovering ONEOK: A Closer Look</h2>
Oneok is a diversified midstream service provider specializing in natural gas gathering, processing, storage, and transportation and natural gas liquids transportation and fractionation. It also operates a refined product and crude oil segment connecting producers, refiners, and consumers. Operations are in the midcontinent, Permian, and Rocky Mountain regions.
<h3>ONEOK: Financial Performance Dissected</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Over the 3 months period, ONEOK showcased positive performance, achieving a revenue growth rate of 19.91% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: ONEOK's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 13.78%, the company may face hurdles in effective cost management.
Return on Equity (ROE): ONEOK's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 4.12%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 1.45%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: ONEOK's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.67.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings For ONEOK

XOMA Royalty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $120.0, a high estimate of $123.00, and a low estimate of $117.00. Observing a 2.56% increase, the current average has risen from the previous average price target of $117.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1733259665_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive XOMA Royalty. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$123.00</td>
<td>$117.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$123.00</td>
<td>$117.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$117.00</td>
<td>$117.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$117.00</td>
<td>$117.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to XOMA Royalty. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of XOMA Royalty compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of XOMA Royalty's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into XOMA Royalty's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/XOMA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on XOMA Royalty analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into XOMA Royalty's Background</h2>
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
<h3>A Deep Dive into XOMA Royalty's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: XOMA Royalty's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -11.57%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: XOMA Royalty's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -2535.56%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): XOMA Royalty's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -20.15%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): XOMA Royalty's ROA stands out, surpassing industry averages. With an impressive ROA of -7.98%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.4, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

XOMA

A Glimpse Into The Expert Outlook On XOMA Royalty Through 4 Analysts

Across the recent three months, 5 analysts have shared their insights on Bank OZK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OZK#NASDAQ">OZK</a>), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Bank OZK, revealing an average target of $49.6, a high estimate of $63.00, and a low estimate of $40.00. Witnessing a positive shift, the current average has risen by 4.2% from the previous average price target of $47.60.
<img src="https://www.benzinga.com/files/images/story/2024/1733259657_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Bank OZK by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jared Shaw</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$40.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$46.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$51.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Stephen Scouten</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$63.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$48.00</td>
<td>$49.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Bank OZK. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Bank OZK compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Bank OZK's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Bank OZK's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/OZK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bank OZK analyst ratings.</a>
<h2>Delving into Bank OZK's Background</h2>
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit and individual retirement accounts to loan services like real estate, consumer, commercial and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking and other related services.
<h3>Financial Milestones: Bank OZK's Journey</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Bank OZK's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 7.64%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Bank OZK's net margin is impressive, surpassing industry averages. With a net margin of 41.88%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Bank OZK's ROE stands out, surpassing industry averages. With an impressive ROE of 3.43%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Bank OZK's ROA stands out, surpassing industry averages. With an impressive ROA of 0.48%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.12, Bank OZK adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 5 Analyst Projections For Bank OZK

Across the recent three months, 14 analysts have shared their insights on Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">12</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $50.36, a high estimate of $57.00, and a low estimate of $44.00. This upward trend is evident, with the current average reflecting a 5.25% increase from the previous average price target of $47.85.
<img src="https://www.benzinga.com/files/images/story/2024/1733259649_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Bank of America among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Scott Siefers</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$57.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Whit Mayo</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Keith Horowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$54.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Chris Kotowski</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Glenn Thum</td>
<td>Phillip Securities</td>
<td>Announces</td>
<td>Accumulate</td>
<td>$44.00</td>
<td>-</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$53.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$50.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Chris Kotowski</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$50.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Gerard Cassidy</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$46.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Chris Kotowski</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$49.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$47.00</td>
<td>$49.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Bank of America. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Bank of America compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Bank of America's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Bank of America's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BAC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bank of America analyst ratings.</a>
<h2>Get to Know Bank of America Better</h2>
Bank of America is one of the largest financial institutions in the United States, with more than $3.0 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
<h3>Bank of America: Delving into Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Positive Revenue Trend: Examining Bank of America's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.71% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Bank of America's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 25.17%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Bank of America's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.37%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Bank of America's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.19%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Bank of America's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.23.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Bank of America's Future

Cannabis-infused edibles producer Grön (pronounced grewn) announced the release of an exclusive flavor available only in Arizona at Curaleaf (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) locations: Prickly Pear. Inspired by the Southwest's vibrant desert landscape, the new flavor will be accessible in two product options: Prickly Pear MEGA, available in a 10-pack and Prickly Pear Sugar-Coated Pearls.
"Arizona is a key market for us, and we are thrilled to create a product that truly resonates with local tastes," stated Christine Apple, founder and CEO of Grön. "The Prickly Pear MEGAs aren't just delicious edibles—they're a celebration of Arizona's unique character and desert culture and the Prickly Pear Pearls will be a perfect addition to our lineup. We're so happy to bring this distinct experience to our Arizona customers."
Read Also: <a href="https://www.benzinga.com/24/12/42279343/nasdaq-listed-weed-stock-hiti-surges-over-21-in-the-last-two-sessions">NASDAQ-Listed Weed Stock, High Tides Surges Over 21% In Last Two Sessions</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
The new products will be exclusively available at all 16 Curaleaf dispensaries in Arizona, marking it as a unique, ongoing offering tailored for Arizona consumers.
The MEGA 10-Packs weighs in at nearly a half pound per pack containing 10 large MEGAs totaling 1,000 milligrams of THC per package. The Prickly Pear Sugar-Coated Pearls will contain 100mg of THC per package, with 10mg THC per pearl.
The Prickly Pear MEGA 10-Pack represents a unique collaboration between Grön and cannabis retail giant Curaleaf. With a balanced sweet-tart taste, the prickly pear flavor is a popular choice among Arizona consumers, who tend to enjoy more high-dose products.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/42050078/curaleaf-secures-first-marijuana-research-license-in-massachusetts">Inside Grön&#8217;s Marijuana Edibles Factory: What Can We Learn About Choco-Nomics And Multi-State Expansion?</a></li>
</ul>
Courtesy photo

Cannabis

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

Grön Launches New Edibles Flavors Across Curaleaf Dispensaries In Arizona

Flora Farms, a prominent cannabis producer in Missouri, voluntarily recalled over 3,000 Zen-brand cannabis gummies last month after state regulators flagged a <a href="https://www.benzinga.com/cannabis">labeling oversight. </a>
The issue? The ingredient list omitted the specific food coloring used in the gummies, Missouri Independent <a href="https://missouriindependent.com/briefs/labeling-error-led-to-missouri-recall-of-cannabis-gummies/">reported.</a>
<h3 class="wp-block-heading">A Regulatory Reminder</h3>
According to Sami Jo Freeman, spokeswoman for Missouri's Division of Cannabis Regulation (DCR), the recall stemmed not from the food coloring itself, which is not banned, but from the omission on the ingredients list.
See Also: <a href="https://www.benzinga.com/24/12/42300451/nasdaq-listed-high-tide-under-the-magnifying-glass-key-insights-for-cannabis-investors">NASDAQ-Listed High Tide Under The Magnifying Glass: Key Insights For Cannabis Investors</a>
"Food coloring must be disclosed in the ingredient list in order to be used in a product," Freeman explained. "This helps consumers know that if they have an allergy to it, that they should not consume that product."
Only one adverse reaction was reported and the incident did not require hospitalization.
<h3 class="wp-block-heading">Cannabis&#8217; Compliance Challenges</h3>
The recall occurred despite <a href="https://www.benzinga.com/topic/missouri-cannabis">Missouri's newly implemented recreational marijuana </a>packaging and labeling rules. Since Sept. 1, manufacturers have been required to submit packaging and labels for pre-approval by the DCR before products reach dispensary shelves. 
However, this process focuses more on design compliance such as ensuring information is included and packaging is not appealing to children, rather than on verifying the accuracy of ingredient lists.
"Verification of whether information is accurate occurs through other processes, such as inspections, complaints, and investigations," Freeman clarified.
Missouri's rules mandate that cannabis packaging feature plain designs with limited colors and minimal branding. These measures aim to comply with the state's constitutional requirement that marijuana-related product packaging "shall not be made to be attractive to children."
Mark Hendren, president of Flora Farms, replied. "DCR requested that Zen labels more specifically identify the food coloring used. So that's what we have done."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42299396/the-state-of-nebraska-is-pushing-back-against-cannabis-both-locally-and-nationally">Nebraska&#8217;s Two-Front War On Cannabis</a></li>
</ul>
Cover image made with AI.

Regulations

Markets

Why This Cannabis Company Recalled Over 3,000 Gummies In Missouri

Analysts' ratings for Interactive Brokers Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) over the last quarter vary from bullish to bearish, as provided by 8 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $167.75, along with a high estimate of $195.00 and a low estimate of $155.00. This upward trend is apparent, with the current average reflecting a 8.31% increase from the previous average price target of $154.88.
<img src="https://www.benzinga.com/files/images/story/2024/1733259610_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of Interactive Brokers Gr by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$195.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$165.00</td>
<td>$166.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$163.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$166.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Daniel Fannon</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$152.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$155.00</td>
<td>$145.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Interactive Brokers Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Interactive Brokers Gr compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Interactive Brokers Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Interactive Brokers Gr's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IBKR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Interactive Brokers Gr analyst ratings.</a>
<h2>About Interactive Brokers Gr</h2>
Interactive Brokers is an online brokerage that generates trading commissions (around 31% of net revenue) from facilitating trading in a wide range of products, including equity, options, futures, foreign exchange, bonds, mutual funds, and exchange-traded funds. Interactive Brokers also generates net interest income (about 64% of net revenue) from idle client cash and earns fees (about 6% of net revenue) from ancillary services. Principal trading and other miscellaneous activities are small (about 5% of net revenue). The firm derives about 70% of its net revenue from the US and 30% from international markets.
<h3>Interactive Brokers Gr: A Financial Overview</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Interactive Brokers Gr's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 18.1%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Interactive Brokers Gr's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 7.68%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Interactive Brokers Gr's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.56%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Interactive Brokers Gr's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.13%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Interactive Brokers Gr's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IBKR

Peeling Back The Layers: Exploring Interactive Brokers Gr Through Analyst Insights

Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) showcased a new product Wednesday that it claims has superior energy efficiency and reduces operational costs for <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence (AI) servers</a>.
Marvell Ara — described as a three-nanometer, 1.6 Terabits per second Pulse Amplitude Modulation 4 (PAM4) interconnect platform with 200 Gigabits per second <a href="https://www.benzinga.com/pressreleases/24/12/n42290742/marvell-unveils-industrys-first-3nm-1-6-tbps-pam4-interconnect-platform-to-scale-accelerated-infra" target="_blank" rel="noreferrer noopener">electrical and optical interfaces</a> — &#8220;sets a new industry standard,&#8221; Vice President Xi Wang <a href="https://www.benzinga.com/pressreleases/24/12/n42290742/marvell-unveils-industrys-first-3nm-1-6-tbps-pam4-interconnect-platform-to-scale-accelerated-infra">stated</a>.
Ara reduces 1.6 Tbps optical module power by over 20%. It will be available for select customers from the first quarter 2025.
Also Read: <a href="https://www.benzinga.com/government/regulations/24/12/42265847/biden-targets-china-with-new-chip-restrictions-nvidia-slides" target="_blank" rel="noreferrer noopener">Biden Targets China With New Chip Restrictions, Nvidia Slides</a> 
On Tuesday, Marvell Technology announced a five-year <a href="https://www.benzinga.com/24/12/42270388/marvell-and-aws-deepen-collaboration-on-cloud-and-ai-solutions-driving-stock-surge-ahead-of-q3-earnings" target="_blank" rel="noreferrer noopener">expanded partnership with</a> Amazon.com Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) cloud unit, Amazon Web Services, Inc . 
The collaboration focused on leveraging cloud infrastructure and driving advancements in data solutions.
Marvell Technology stock has gained 68% year-to-date as a critical supplier of semiconductor solutions for data centers, AI infrastructure, and networking.
DZ BANK AG,&nbsp;California Public Employees Retirement System,&nbsp;UBS Group AG,&nbsp;Invesco Ltd, and&nbsp;T. Rowe Price Associates Inc&nbsp;ramped stakes in Marvell Technology in <a target="_blank" href="https://www.benzinga.com/markets/equities/24/12/42260202/goldman-sachs-morgan-stanley-bank-of-montreal-cut-positions-in-marvell-technology-invesco-t-rowe-price-doubled-down" rel="noreferrer noopener">the third quarter</a>. Meanwhile,&nbsp;Morgan Stanley,&nbsp;Bank of Montreal Can,&nbsp;Clearbridge Investments, LLC, and&nbsp;Goldman Sachs&nbsp;reduced their exposure to the stock.
Analyst&nbsp;Blayne Curtis finds Marvell Technology <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41896181/nancy-pelosis-stock-pick-broadcom-and-nvidia-among-other-key-ai-stock-poised-for-chip-boom-says-analyst" rel="noreferrer noopener">well-positioned to tap</a> the&nbsp;AI chip frenzy.
Price Action: MRVL stock is up 0.72% at $97.57 at last check Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/media/24/12/42269848/amazons-aws-ceo-teases-major-ai-advancements" target="_blank" rel="noreferrer noopener">Amazon&#8217;s AWS CEO Teases Major AI Advancements</a></li>
</ul>
Image: Shutterstock

Tech

AMZN

MRVL

Marvell Unveils New Platform, Targets Growing AI Bandwidth Demands

Canopy Growth Corporation (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WEED#TSX">WEED</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) and Acreage Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRG#CSE">ACRG</a>, ACRG.B.U))(OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ACRHF#OTCQX">ACRHF</a>, ACRDF)) announced Monday that Canopy USA, LLC will complete its acquisition of Acreage on or around Dec. 9, 2024.
The Canadian cannabis giant announced its plans to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/19/06/13951090/canopy-shareholders-approve-acreage-deal-legalization-in-focus">acquire</a> Acreage for $3.4 billion in 2019. Initially, the deal was to be undertaken should the U.S. legalize&nbsp;marijuana on a federal level. That deal was later restructured.
The deal outlined the plan to acquire all Class E subordinate voting shares of Acreage. This acquisition will follow the purchase of the Class D shares of Acreage, based on an agreement from October 24, 2022. After both acquisitions are completed, Canopy USA will own all shares of Acreage.
Acreage pointed out in November that the move could leave holders of Acreage's Class E shares (fixed shares) with nothing if Canopy's stock price remains <a href="https://www.benzinga.com/24/11/42196557/canopy-usas-acquisition-of-acreage-could-mean-loss-for-some-shareholders-heres-why">below $5 when the deal closes</a>.
Canopy Growth's shares traded 6.71% lower at $3.545 per share at the time of writing on Tuesday December 3. Acreage's shares traded 11.63% higher at $0.12 per share.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39185620/acreage-announces-10m-private-placement-of-units-ahead-of-acquisition-by-canopy">Acreage Announces $10M Private Placement Of Units Ahead Of Acquisition By Canopy</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Canopy USA &#8211; Canopy Growth‘s strategy for capturing the U.S. cannabis market &#8211; was created in 2022. A new U.S.-domiciled holding company is set to streamline the company's entry into the US market by allowing it to acquire Acreage as well as two other cannabis companies – Wana Brands and Jetty – while also holding a minority stake in TerrAscend. Corp. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TSND#TSX">TSND</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TSNDF#OTCQX">TSNDF</a>).
Canopy USA <a href="https://www.benzinga.com/markets/cannabis/24/10/41251114/cannabis-giant-canopy-expands-us-presence-with-acquisition-of-top-edibles-brand-what-it-means-fo">completed</a> its acquisition of Wana in October, and roughly 75% of the shares of cannabis edibles producer, Lemurian, Inc. (Jetty) as <a href="https://www.benzinga.com/markets/cannabis/24/06/39166300/canopy-growth-doubles-down-on-its-usa-strategy-announces-exercise-of-acreage-options">announced in June 2024.</a>
Canopy Growth&#8217;s newly appointed CEO Luc Mongeau, who succeeds David Klein effective Jan. 6, 2025, will continue his legacy by expanding the company&#8217;s influence in the U.S.
Read Also: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/42162875/canopy-growths-german-subsidiary-teams-up-with-portugals-gro-vida-to-expand-medical-cannabis-supply">Canopy Growth&#8217;s German Subsidiary Teams Up With Portugal&#8217;s Gro-Vida To Expand Medical Cannabis Supply</a></li>
</ul>

ACRDF

ACRHF

CSE:ACRG

TSNDF

TSX:TSND

TSX:WEED

WEED

Canopy Growth Set To Complete Acreage Acquisition, Leaving Some Shareholders Potentially Open To Losses

Boston Scientific's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) short percent of float has fallen 14.77% since its last report. The company recently reported that it has 11.02 million shares sold short, which is 0.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.92 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Boston Scientific Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733258722_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Boston Scientific has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Boston Scientific's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Boston Scientific's peer group average for short interest as a percentage of float is 4.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(BSX) - Analyzing Boston Scientific's Short Interest

LGMK

LogicMark 13D/Amended Filing Shows Winvest Investment Fund Management Corp Dissolved Stake In The Co As Of Nov 22

Estee Lauder Cos's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) short percent of float has risen 55.76% since its last report. The company recently reported that it has 7.86 million shares sold short, which is 3.38% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Estee Lauder Cos Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733258716_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Estee Lauder Cos has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Estee Lauder Cos's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Estee Lauder Cos's peer group average for short interest as a percentage of float is 5.34%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Estee Lauder Cos's Recent Short Interest

HCA Healthcare's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) short percent of float has risen 14.39% since its last report. The company recently reported that it has 2.97 million shares sold short, which is 1.59% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>HCA Healthcare Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733258711_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for HCA Healthcare has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing HCA Healthcare's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, HCA Healthcare's peer group average for short interest as a percentage of float is 4.17%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into HCA Healthcare's Recent Short Interest

ORIS

Oriental Rise Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 39%

Chanson International prices $7.27M public offering; stock falls

Chanson International Holding Class A (CHSN) has released an update. Chanson International Holding has announced that holders of its Class A Ordina...

Chanson International Opens Warrant Exercise Window

Chanson International Holding Class A (CHSN) has released an update. Chanson International Holding has announced a significant amendment to their C...

Chanson International Updates Warrant Terms for Holders

Chanson International Holding Class A (CHSN) has released an update. Chanson International Holding has released its unaudited condensed consolidate...

Chanson International Reports Mid-Year Financials

Chanson International reports 1H results

Chanson International Holding Class A (CHSN) has released an update. Chanson International Holding has announced a temporary suspension of trading ...

Chanson International Faces Trading Suspension and Inquiry

09:39 EST Chanson International (CHSN) Holding trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-ti...

Chanson International Holding trading halted, volatility trading pause

Chanson International (CHSN) announced that it expects its total number of chain stores across China and the United States to reach 60 by the end o...

Chanson International expects significant progress in store expansion

Chanson International (CHSN) announces a collaboration with a leading hotel and restaurant management enterprise in Yili, Xinjiang, China, Xinjiang...

Chanson International announces collaboration with Soul Song

Chanson International Holding Class A (CHSN) has released an update. Chanson International Holding is set to hold an extraordinary general meeting ...

Chanson International Holding to Vote on Shareholder Resolutions

CHSN

Screenshot 2024-12-03 at 8.06.31 PM

Movers & Shakers

Chanson International Closing The Year In Expansion Mode

Press Releases

Chanson International Holding Announces the Plan to Grow Its New Coffee Brand in China

Chanson International Holding Announces Fiscal Year 2023 Financial Results

Financing

Chanson International Holding Announces Pricing of $7.274 Million Public Offering

Chanson International Holding Announces Closing of $7.274 Million Public Offering

Chanson International Holding Announces First Half of Fiscal Year 2024 Financial Results

Chanson International Holding Expects Significant Progress in Store Expansion

Chanson International Holding Announces a Collaboration under Coffee Brand Soul ● Song in Xinjiang, China

Albertsons Companies, Inc. Class A Common Stock

Albertsons Companies

Maplebear

Caseys General Stores, Inc. - Common Stock

Casey's General Stores

Dingdong (Cayman) Limited American Depositary Shares (each two representing three Ordinary Shares)

Comments

Chanson International

Chanson International (CHSN) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル